Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 224

Sort by

Sort Order Select

Journal Articles

Tigit: The Potential Mechanisms of Relapse in Multiple Myeloma Following Anti-BCMA CAR-T Therapy and a Promising Target for Improving CAR-T Efficacy

Yuan Xia, Xuxing Shen, Min Shi, Na Shen, Yu Zhu, Lei Fan, Jianyong Li, Lijuan Chen

Blood (2024) 144 (Supplement 1): 2033.

https://doi.org/10.1182/blood-2024-205126

Published: 2024

Journal Articles

Role and Mechanisms Exploration of Histamine and Its Receptors in the Progression of Peripheral T-Cell Lymphoma

Hui Jin, Ling Wang, Yimin Ren, Zijuan Wu, Wenyu Shi, Jianyong Li

Blood (2024) 144 (Supplement 1): 4378.

https://doi.org/10.1182/blood-2024-211896

Published: 2024

Journal Articles

Glycosylation Single-Cell Transcriptomic Profiling Decodes Driver Mechanism and Genetic Characteristics of Circulating Plasma Cells in Multiple Myeloma

Xiaoyan Qu, Yating Li, Zhengxu Sun, Wanting Ying, Hailing Liu, Sanmei Wang, Miao Zhong, Jianyong Li, Lei Fan

Blood (2024) 144 (Supplement 1): 1902.

https://doi.org/10.1182/blood-2024-206525

Published: 2024

Journal Articles

Single-Cell Transcriptome Analysis Reveals the Novel Subtypes and Therapeutic Implications of T-Lymphoid/Myeloid Mixed-Phenotype Acute Leukemia

Ming Hong, Bin Huang, Wenjie Liu, Qian Sun, Jianyong Li, Sixuan Qian, Qianghu Wang, Kening Li

Blood (2024) 144 (Supplement 1): 1549.

https://doi.org/10.1182/blood-2024-198791

Published: 2024

Journal Articles

Exploration of the Specific Mechanism of EGR2 Hotspot Mutation Mediating the Upregulation of Galectin-1 Expression in the Progression of CLL Following Treatment with BTK Inhibitor

Xiao Lu, Yeqin Sha, Xinyu Song, Luomengjia Dai, Ziyuan Zhou, Hanning Tang, Yi Miao, Shuchao Qin, Yi Xia, Tonglu Qiu, Lei Fan, Jianyong Li, Huayuan Zhu

Blood (2024) 144 (Supplement 1): 4612.

https://doi.org/10.1182/blood-2024-207729

Published: 2024

Journal Articles

Phase 1 Study of TT-01488, a Novel, Non-Covalent, Reversible BTK Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies

Yufu Li, Wei Xu, Caixia Li, Pengcheng He, Wei Yang, Xiangmin Tong, Ying Wang, Hongchan Zhang, Caixia Sun, Zejuan Sheng, Jean Fan, Jianyong Li

Blood (2024) 144 (Supplement 1): 3036.

https://doi.org/10.1182/blood-2024-202976

Published: 2024

Journal Articles

Orelabrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (OFCG) for First-Line Treatment of Chronic Lymphocytic Leukemia: A Multicenter, Investigator-Initiated Study (cwCLL-001 Study)

Huayuan Zhu, Yi Miao, Shuchao Qin, Ming Liu, Yi Xia, Luomengjia Dai, Tonglu Qiu, Chong-Yang Ding, Hairong Qiu, Chun Qiao, Yujie Wu, Fei Li, Xiao Lu, Wei Xu, Lei Fan, Jianyong Li

Blood (2024) 144 (Supplement 1): 3244.

https://doi.org/10.1182/blood-2024-204881

Published: 2024

Journal Articles

Endothelial Activation and Stress Index (EASIX) to Predict Survival in T or NK Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

Blood (2024) 144 (Supplement 1): 1685.

https://doi.org/10.1182/blood-2024-205535

Published: 2024

Journal Articles

Multi-Omics Profiling Reveals Tumor Cellular Landscape and Metabolism Remodeling during Extranodal Natural Killer/T-Cell Lymphoma (ENKTL) Metastasis and Progression

Jinhua Liang, Kai-Xin Du, Yue Li, Tong-Yao Xing, Hao-Rui Shen, Jiazhu Wu, Hua Yin, Li Wang, Jianyong Li, Xu Wei

Blood (2024) 144 (Supplement 1): 2961.

https://doi.org/10.1182/blood-2024-201455

Published: 2024

Journal Articles

Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma: Insights from the Phase 2 Fumanba-1 Study

Chunrui Li, Dehui Zou, Di Wang, Baijun Fang, He Huang, Jianyong Li, Bing Chen, Jing Liu, Xi Zhang, Yujun Dong, Kai Hu, Peng Liu, Jianqing Mi, Kaiyang Ding, Zhenyu Li, Qie Dong, Fuyuan Zhang, Guang Hu, Lu-Gui Qiu

Blood (2024) 144 (Supplement 1): 4761.

https://doi.org/10.1182/blood-2024-204355

Published: 2024

Journal Articles

The First-in-Class PTPN2/1 Inhibitor Abbv-CLS-484 Disrupts Mitochondrial Renewal and Blocks Tfrc-Mediated PINK1-Prkn-Dependent Mitophagy to Exert Anti-Tumor Activities in ALK-Positive Anaplastic Large Cell Lymphoma

Jinhua Liang, Weiting Wang, Ziwen Duan, Tong-Yao Xing, Hao-Rui Shen, Hua Yin, Li Wang, Jianyong Li, Xu Wei

Blood (2024) 144 (Supplement 1): 2742.

https://doi.org/10.1182/blood-2024-201488

Published: 2024

Journal Articles

Novel Targeted Agents in Combination with R-MINE (RMINE+X) Based on Different Molecular Subtypes in Relapsed/Refractory Diffuse Large B-Cell Lymphoma：a Phase 2 Multicenter Study

Jinhua Liang, Hao-Rui Shen, Hua Yin, Jiazhu Wu, Yue Li, Li Wang, Lintao Bi, Weiwei Qin, Jianyong Li, Xu Wei

Blood (2024) 144 (Supplement 1): 1725.

https://doi.org/10.1182/blood-2024-202967

Published: 2024

Journal Articles

Torque Teno Viruses Infection Associated with Suboptimal Hematological Recovery of Severe Aplastic Anemia

Yuemin Gong, Yawen Zhang, Jianyong Li, Guangsheng He, Lei Fan

Blood (2024) 144 (Supplement 1): 2702.

https://doi.org/10.1182/blood-2024-202874

Published: 2024

Journal Articles

Decitabine before Low-Dose Cytarabine-Based Chemotherapy Combined with Unrelated Umbilical Cord Blood Stem Cell Microtransplantation and IL-2 Treatment in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Ming Hong, Wenjie Liu, Qian Sun, Jianyong Li, Sixuan Qian

Blood (2024) 144 (Supplement 1): 1501.

https://doi.org/10.1182/blood-2024-210245

Published: 2024

Journal Articles

Clinical Implications of Ctdna-Based Minimal Residual Disease Detection in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Jinhua Liang, Yi-fan Wu, Hao-Rui Shen, Jiazhu Wu, Jun-heng Liang, Liu-Qing Zhu, Hua Yin, Yue Li, Li Wang, Jianyong Li, Xu Wei

Blood (2024) 144 (Supplement 1): 1709.

https://doi.org/10.1182/blood-2024-201220

Published: 2024

Journal Articles

Efficacy and Safety of Zanubrutinib Monotherapy in Real-World Chinese CLL/SLL Patients

Shenmiao Yang, Huayuan Zhu, Ru Feng, Xutao Guo, Ting Niu, Jian-Qing Mi, Zhenling Li, Qianqian Ju, Liru Wang, Yujun Dong, Bingjie Wang, Liang Wang, Wanling Sun, Fang Fang, Liping Su, Yu Zhao, Xiaojun Huang, Jianyong Li

Blood (2024) 144 (Supplement 1): 6773.

https://doi.org/10.1182/blood-2024-206560

Published: 2024

Journal Articles

Acalabrutinib in Chinese Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: 24-Month Efficacy and Safety Results from an Open-Label, Multicenter Phase 1/2 Trial

Shenmiao Yang, Haiwen Huang, Keshu Zhou, Xielan Zhao, Yanqiu Han, Lindong Li, Yujie Wang, Xiaofeng Liu, Jianyong Li

Blood (2024) 144 (Supplement 1): 6767.

https://doi.org/10.1182/blood-2024-193416

Published: 2024

Journal Articles

Combination of Geriatric Assessment and Clinical Factors to Predict the Survival of Elderly Patients with Myeloma

Yuanyuan Jin, Ruoru Liu, Jianyong Li, Lei Fan, Lijuan Chen

Blood (2024) 144 (Supplement 1): 6951.

https://doi.org/10.1182/blood-2024-204360

Published: 2024

Journal Articles

Combining Intensive Immunosuppressive Therapy with Eltrombopag in the Severe Aplastic Anemia: Mild Aggravation of Hepatic Injury

Xiaoyu Chen, Chengtao Qin, Ting Zhang, Yuemin Gong, Yawen Zhang, Guangsheng He, Jianyong Li

Blood (2024) 144 (Supplement 1): 5678.

https://doi.org/10.1182/blood-2024-203363

Published: 2024

Journal Articles

Gene Mutation Profiles of Primary Pure Red Cell Aplasia and Large Granular Lymphocytic Leukemia Associated Pure Red Cell Aplasia

Yawen Zhang, Yuemin Gong, Xiaoqing Liu, Guangsheng He, Lei Fan, Jianyong Li

Blood (2024) 144 (Supplement 1): 5676.

https://doi.org/10.1182/blood-2024-202927

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Tigit: The Potential Mechanisms of Relapse in Multiple Myeloma Following Anti-BCMA CAR-T Therapy and a Promising Target for Improving CAR-T Efficacy

Role and Mechanisms Exploration of Histamine and Its Receptors in the Progression of Peripheral T-Cell Lymphoma

Glycosylation Single-Cell Transcriptomic Profiling Decodes Driver Mechanism and Genetic Characteristics of Circulating Plasma Cells in Multiple Myeloma

Single-Cell Transcriptome Analysis Reveals the Novel Subtypes and Therapeutic Implications of T-Lymphoid/Myeloid Mixed-Phenotype Acute Leukemia

Exploration of the Specific Mechanism of EGR2 Hotspot Mutation Mediating the Upregulation of Galectin-1 Expression in the Progression of CLL Following Treatment with BTK Inhibitor

Phase 1 Study of TT-01488, a Novel, Non-Covalent, Reversible BTK Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies

Orelabrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (OFCG) for First-Line Treatment of Chronic Lymphocytic Leukemia: A Multicenter, Investigator-Initiated Study (cwCLL-001 Study)

Endothelial Activation and Stress Index (EASIX) to Predict Survival in T or NK Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

Multi-Omics Profiling Reveals Tumor Cellular Landscape and Metabolism Remodeling during Extranodal Natural Killer/T-Cell Lymphoma (ENKTL) Metastasis and Progression

Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma: Insights from the Phase 2 Fumanba-1 Study

The First-in-Class PTPN2/1 Inhibitor Abbv-CLS-484 Disrupts Mitochondrial Renewal and Blocks Tfrc-Mediated PINK1-Prkn-Dependent Mitophagy to Exert Anti-Tumor Activities in ALK-Positive Anaplastic Large Cell Lymphoma

Novel Targeted Agents in Combination with R-MINE (RMINE+X) Based on Different Molecular Subtypes in Relapsed/Refractory Diffuse Large B-Cell Lymphoma：a Phase 2 Multicenter Study

Torque Teno Viruses Infection Associated with Suboptimal Hematological Recovery of Severe Aplastic Anemia

Decitabine before Low-Dose Cytarabine-Based Chemotherapy Combined with Unrelated Umbilical Cord Blood Stem Cell Microtransplantation and IL-2 Treatment in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Clinical Implications of Ctdna-Based Minimal Residual Disease Detection in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Efficacy and Safety of Zanubrutinib Monotherapy in Real-World Chinese CLL/SLL Patients

Acalabrutinib in Chinese Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: 24-Month Efficacy and Safety Results from an Open-Label, Multicenter Phase 1/2 Trial

Combination of Geriatric Assessment and Clinical Factors to Predict the Survival of Elderly Patients with Myeloma

Combining Intensive Immunosuppressive Therapy with Eltrombopag in the Severe Aplastic Anemia: Mild Aggravation of Hepatic Injury

Gene Mutation Profiles of Primary Pure Red Cell Aplasia and Large Granular Lymphocytic Leukemia Associated Pure Red Cell Aplasia

Email alerts

ASH Publications

American Society of Hematology